Trial Profile
Industry-sponsored clinical trial of GEN 0101 (HVJ-E) in patients with castrate-resistant prostate cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2011
Price :
$35
*
At a glance
- Drugs GEN 0101 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 23 Nov 2011 New trial record